The recent Biocidal Products Committee meeting has been held in December. The Biocidal Products Committee has adopted 16 opinions from the recent BPC meeting. In which, 10 on the approval of active substances, two on Union authorization, and four addressing requests from the European Commission.

The following are the positive opinions adopted by the Biocidal Products Committee.

Active Substance Approvals:

  1. 1. Ozone generated from oxygen for use in disinfectants and algaecides not intended for use directly on people or animals (product-type 2), in disinfectants for food and feed area (product-type 4) and drinking water (product-type 5), and preservatives for liquid-cooling and processing systems (product-type 11);
  2. 2. Alkyl (C12-16) dimethyl benzyl ammonium chloride for use in disinfectants for personal hygiene (product-type 1) and product-type 2;
  3. 3. Chrysanthemum cineraria folium, an extract from flowers of Tanacetum cinerariifolium, obtained with supercritical carbon dioxide and with hydrocarbon solvents for repellents and attractants (product-type 19); and
  4. 4. Didecyldimethylammonium chloride (DDAC) for product-types 1 and 2.

Union Authorizations:  

  • ➢  Hydrogen peroxide for product-type 2.
  • ➢  Hydrogen peroxide for product-type 2.

Both European Commission and the EU Member States will work together to make the final decision on approval of active substances and Union authorization of biocidal product families. In addition, the BPC has adopted the following opinions for addressing requests by the European Commission on: Evaluation of the risks for human health and the environment from endocrine-disrupting properties of 2,2-dibromo-2-cyanoacetamide (DBNPA) used in disinfectants for food and feed area (product-type 4). The committee concluded that the level of risk can be considered acceptable. Evaluation of the risks for human health and the environment from endocrine-disrupting properties of cyanamide used in disinfectants for veterinary hygiene (product-type 3) and in products to treat against insects, arachnids, and other anthropods (product-type 18). The committee could not conclude on the risks based on the available data.

Eligibility of the active substance peanut butter to be included in Annex I to the BPR, which lists active substances identified as having a low risk and being eligible for a simplified authorization process. The committee recommends that peanut butter will not be included in Annex I as it can be considered immunotoxic (can cause allergic reactions). Questions relating to guidance on rodent traps developed by the German Environment Agency. The committee concluded that the same principles for the evaluation of efficacy are used in this guidance compared to chemical-based rodenticides. The European Commission will make the final decisions based on BPC’s technical and scientific advice and the same will be available on the BPC’s web page soon.

Reach out to our regulation experts on product regulatory compliances